Cargando…

Patient pathways and delays to diagnosis and treatment of tuberculosis in an urban setting in Indonesia

BACKGROUND: Understanding patient pathways can help align patient preferences and tuberculosis (TB) related services. We investigated patient pathways, and diagnostic and treatment delays among TB patients in Indonesia, which has one of the highest proportions of non-notified TB cases globally. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Lestari, Bony Wiem, McAllister, Susan, Hadisoemarto, Panji Fortuna, Afifah, Nur, Jani, Ira Dewi, Murray, Megan, van Crevel, Reinout, Hill, Philip C, Alisjahbana, Bachti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315599/
https://www.ncbi.nlm.nih.gov/pubmed/34327397
http://dx.doi.org/10.1016/j.lanwpc.2020.100059
_version_ 1783729749515829248
author Lestari, Bony Wiem
McAllister, Susan
Hadisoemarto, Panji Fortuna
Afifah, Nur
Jani, Ira Dewi
Murray, Megan
van Crevel, Reinout
Hill, Philip C
Alisjahbana, Bachti
author_facet Lestari, Bony Wiem
McAllister, Susan
Hadisoemarto, Panji Fortuna
Afifah, Nur
Jani, Ira Dewi
Murray, Megan
van Crevel, Reinout
Hill, Philip C
Alisjahbana, Bachti
author_sort Lestari, Bony Wiem
collection PubMed
description BACKGROUND: Understanding patient pathways can help align patient preferences and tuberculosis (TB) related services. We investigated patient pathways, and diagnostic and treatment delays among TB patients in Indonesia, which has one of the highest proportions of non-notified TB cases globally. METHODS: We conducted a study of TB patients recruited from Community Health Centers (CHCs), public and private hospitals, and private practitioners from 2017 to 2019 in Bandung City, regarding general characteristics and symptoms, and health-seeking, diagnostic and treatment pathways. FINDINGS: We recruited 414 TB patients: 138 (33%) in CHCs, 210 (51%) in hospitals, 66 (20%) in private practitioners. Most patients (74·6%) first sought care at an informal or private provider and experienced a complex pathway visiting both public and private providers to obtain a diagnosis. The median number of health provider visits pre-diagnosis was 6 (IQR 4–8). From start of symptoms, it took a median 30 days (IQR 14–61) to present to a health provider, 62 days (IQR 35–113) to reach a TB diagnosis, and 65 days (IQR 37–119) to start treatment. Patient delay was longer among male, lowly-educated and uninsured individuals. There were longer diagnostic delays among uninsured individuals, those who initially visited private providers, and those with multiple visits prior to diagnosis. Longer treatment delays were found in those with multiple pre-diagnosis visits or diagnosed by private practitioners. INTERPRETATION: Patient pathways in Indonesia are complex, involving the public and private sector, with multiple visits and long delays, especially to diagnosis. A widely available accurate diagnostic test for TB could have a dramatic effect on reducing delays, onward transmission and mortality. FUNDING: This project was funded by the Partnership for Enhanced Engagement in Research (PEER) grant under Prime Agreement Number AID-OAA-A-11–00,012 by National Academy of Sciences (NAS); the United States Agency for International Development (USAID); University of Otago, New Zealand, and the Indonesian Endowment Fund for Education (LPDP).
format Online
Article
Text
id pubmed-8315599
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-83155992021-07-28 Patient pathways and delays to diagnosis and treatment of tuberculosis in an urban setting in Indonesia Lestari, Bony Wiem McAllister, Susan Hadisoemarto, Panji Fortuna Afifah, Nur Jani, Ira Dewi Murray, Megan van Crevel, Reinout Hill, Philip C Alisjahbana, Bachti Lancet Reg Health West Pac Research Paper BACKGROUND: Understanding patient pathways can help align patient preferences and tuberculosis (TB) related services. We investigated patient pathways, and diagnostic and treatment delays among TB patients in Indonesia, which has one of the highest proportions of non-notified TB cases globally. METHODS: We conducted a study of TB patients recruited from Community Health Centers (CHCs), public and private hospitals, and private practitioners from 2017 to 2019 in Bandung City, regarding general characteristics and symptoms, and health-seeking, diagnostic and treatment pathways. FINDINGS: We recruited 414 TB patients: 138 (33%) in CHCs, 210 (51%) in hospitals, 66 (20%) in private practitioners. Most patients (74·6%) first sought care at an informal or private provider and experienced a complex pathway visiting both public and private providers to obtain a diagnosis. The median number of health provider visits pre-diagnosis was 6 (IQR 4–8). From start of symptoms, it took a median 30 days (IQR 14–61) to present to a health provider, 62 days (IQR 35–113) to reach a TB diagnosis, and 65 days (IQR 37–119) to start treatment. Patient delay was longer among male, lowly-educated and uninsured individuals. There were longer diagnostic delays among uninsured individuals, those who initially visited private providers, and those with multiple visits prior to diagnosis. Longer treatment delays were found in those with multiple pre-diagnosis visits or diagnosed by private practitioners. INTERPRETATION: Patient pathways in Indonesia are complex, involving the public and private sector, with multiple visits and long delays, especially to diagnosis. A widely available accurate diagnostic test for TB could have a dramatic effect on reducing delays, onward transmission and mortality. FUNDING: This project was funded by the Partnership for Enhanced Engagement in Research (PEER) grant under Prime Agreement Number AID-OAA-A-11–00,012 by National Academy of Sciences (NAS); the United States Agency for International Development (USAID); University of Otago, New Zealand, and the Indonesian Endowment Fund for Education (LPDP). Elsevier 2020-11-28 /pmc/articles/PMC8315599/ /pubmed/34327397 http://dx.doi.org/10.1016/j.lanwpc.2020.100059 Text en © 2020 The Authors. Published by Elsevier Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Paper
Lestari, Bony Wiem
McAllister, Susan
Hadisoemarto, Panji Fortuna
Afifah, Nur
Jani, Ira Dewi
Murray, Megan
van Crevel, Reinout
Hill, Philip C
Alisjahbana, Bachti
Patient pathways and delays to diagnosis and treatment of tuberculosis in an urban setting in Indonesia
title Patient pathways and delays to diagnosis and treatment of tuberculosis in an urban setting in Indonesia
title_full Patient pathways and delays to diagnosis and treatment of tuberculosis in an urban setting in Indonesia
title_fullStr Patient pathways and delays to diagnosis and treatment of tuberculosis in an urban setting in Indonesia
title_full_unstemmed Patient pathways and delays to diagnosis and treatment of tuberculosis in an urban setting in Indonesia
title_short Patient pathways and delays to diagnosis and treatment of tuberculosis in an urban setting in Indonesia
title_sort patient pathways and delays to diagnosis and treatment of tuberculosis in an urban setting in indonesia
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315599/
https://www.ncbi.nlm.nih.gov/pubmed/34327397
http://dx.doi.org/10.1016/j.lanwpc.2020.100059
work_keys_str_mv AT lestaribonywiem patientpathwaysanddelaystodiagnosisandtreatmentoftuberculosisinanurbansettinginindonesia
AT mcallistersusan patientpathwaysanddelaystodiagnosisandtreatmentoftuberculosisinanurbansettinginindonesia
AT hadisoemartopanjifortuna patientpathwaysanddelaystodiagnosisandtreatmentoftuberculosisinanurbansettinginindonesia
AT afifahnur patientpathwaysanddelaystodiagnosisandtreatmentoftuberculosisinanurbansettinginindonesia
AT janiiradewi patientpathwaysanddelaystodiagnosisandtreatmentoftuberculosisinanurbansettinginindonesia
AT murraymegan patientpathwaysanddelaystodiagnosisandtreatmentoftuberculosisinanurbansettinginindonesia
AT vancrevelreinout patientpathwaysanddelaystodiagnosisandtreatmentoftuberculosisinanurbansettinginindonesia
AT hillphilipc patientpathwaysanddelaystodiagnosisandtreatmentoftuberculosisinanurbansettinginindonesia
AT alisjahbanabachti patientpathwaysanddelaystodiagnosisandtreatmentoftuberculosisinanurbansettinginindonesia